Covid update

Complex formulations for parenteral drug delivery

Biopharmaceutical and generic companies that are looking for a manufacturer of their complex formulation with their own Active Pharmaceutical Ingredient, have a great partner in BioConnection. We offer our full-fledged production facilities for the GMP manufacturing of microspheres, liposomes, nanoparticles, microparticles and more.

BioConnection offers several options for complex formulations:

– Transfering your own production process

You can transfer your own production process (and if necessary your dedicated equipment) for a complex formulation to our facility. Whether this is a microsphere, liposome or nanoparticle, we will set up the proper production line and implement your process in our facility. Consequently, we will validate the production process and produce your product according to your requirements.

– Developing a personalized production process at BioConnection

The second option is that we develop the appropriate production process for you, based on a specific technology or based on our own production process for microspheres (a patented technology). When you identify the API, we will produce the appropriate microsphere, loaded with API and with the right size and with the requested release profile. Of course, the production will be all according to GMP regulations.

Both options can be combined with ourĀ Fill and Finish and analytical services. This will render you a drug product that is ready for clinical trials and subsequent market-launch.

Location of the production facility

In case you are interested in letting BioConnection produce your biopharmaceutical product, you can easily get in touch with us. Besides, you can always make an appointment to visit production facility for complex formulation, which is located in the Pivot Park in Oss, The Netherlands.

What can we do for you?

We are definitely open for a challenge, so if you have a complex formulation that needs to be developed or manufactured, please contact us. The BioConnection team will do everything to fulfill (and finish) your biopharmaceutical needs.


Covid-19 update BioConnection

BioConnection has taken precautions related to the global outbreak of the Covid-19 virus. To start with; we are currently in full operation and running on-schedule with regard to our planned productions. Our production department is on full strength and we have no shortages of material(s) nor do we foresee them.

For our personnel we are following the guidelines as issued by the Dutch National Institute for Public Health and the Environment, RIVM ( This means that people stay at home when they show (early) symptoms connected to Covid-19. Furthermore BioConnection employees work from home as much as possible. We avoid shaking hands and keep distance from each other. We take every precaution as advised to prevent the spread of the Covid-19 virus and will fully comply to the requests as stated and/or enforced by the authorities.

Our expansion project ( is running as planned to start GMP production in Q2 2021. We stay in close contact with our suppliers for the production equipment.

We review for Covid policy changes by the authorities on a daily base and adapt to them. If changes occur, this statement will be updated accordingly so you always have the latest information. In case you have any questions, please do not hesitate to contact us via our general number or website. Current customers of BioConnection, can contact their dedicated program manager. In case you want BioConnection to become a partner in your development or manufacturing, please contact our Business Development department via

The BioConnection Management Team.

You have Successfully Subscribed!